top of page
Report Summary
Market Overview

Global Tissue Diagnostics Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)

Global Tissue Diagnostics Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)


Market Segmentation: By Product (Instruments, and Reagents and Consumables), Technology (Immunohistochemistry, In-situ Hybridization, Digital Pathology and Workflow Management, and Other Technologies), Application (Breast Cancer, Prostate Cancer, Gastric Cancer, and Other Cancers), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)


Market Overview


The Global Tissue Diagnostics Market was valued at USD 5,668.3 million in 2023 and is expected to reach USD 10,967.0 million by 2031 while growing at a CAGR of 8.6% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Market Dynamics


This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global tissue diagnostics market growth. Tissue diagnostics, also termed histopathology or surgical pathology, involves analyzing tissue samples from patients to diagnose, prognose, and treat various diseases and conditions. This branch of pathology is crucial for medical diagnosis and treatment.


Continuous innovation in tissue diagnostic technologies, including immunohistochemistry, in situ hybridization, and digital pathology, is being fueled by the rising incidence of cancer. Nevertheless, the high cost of diagnostic tests and regulatory challenges could hinder the growth of the tissue diagnostics market.


Furthermore, the global tissue diagnostics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.


Segmentation – By Product Analysis


The Global Tissue Diagnostics Market is segmented among Instruments, and Reagents and Consumables, based on Product. In 2023, Reagents and Consumables accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Segmentation – By Technology Analysis


The Global Tissue Diagnostics Market is segmented among Immunohistochemistry, In-situ Hybridization, Digital Pathology and Workflow Management, and Other Technologies, based on Technology. In 2023, Immunohistochemistry accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Global Tissue Diagnostics Market: Regional Analysis


Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Competitive Landscape


Some of the key players operating in the market are Abbott Laboratories, Agilent Technologies Inc., BioGenex Laboratories, ILLUMINA Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Qiagen NV, Merck KGaA, and Thermo Fisher Scientific Inc.


Table of Contents:


1. Research Methodology and Market Scope

  • Research Methodology

  • Market Scope

2. Executive Summary

3. Global Tissue Diagnostics Market Dynamics

  • Drivers

  • Restraints

  • Opportunity

4. Global Tissue Diagnostics Industry Analysis

  • PEST Analysis

  • Porter's Five Force Analysis

  • Recent Deals Analysis

5. Global Tissue Diagnostics Market Segmentation, By Product

  • Global Tissue Diagnostics Market Share Analysis, By Product

  • Global Tissue Diagnostics Market Growth Analysis, By Product

  • Global Tissue Diagnostics Market Trends, By Product

o Instruments

o Reagents and Consumables

6. Global Tissue Diagnostics Market Segmentation, By Technology

  • Global Tissue Diagnostics Market Share Analysis, By Technology

  • Global Tissue Diagnostics Market Growth Analysis, By Technology

  • Global Tissue Diagnostics Market Trends, By Technology

o Immunohistochemistry

o In-situ Hybridization

o Digital Pathology and Workflow Management

o Other Technologies

7. Global Tissue Diagnostics Market Segmentation, By Application

  • Global Tissue Diagnostics Market Share Analysis, By Application

  • Global Tissue Diagnostics Market Growth Analysis, By Application

  • Global Tissue Diagnostics Market Trends, By Application

o Breast Cancer

o Prostate Cancer

o Gastric Cancer

o Other Cancers

8. Global Tissue Diagnostics Market Segmentation, By Region

  • Global Tissue Diagnostics Market Share Analysis, By Region

  • Global Tissue Diagnostics Market Growth Analysis, By Region

  • Global Tissue Diagnostics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

  • Abbott Laboratories*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

  • Agilent Technologies Inc.

  • BioGenex Laboratories

  • ILLUMINA Inc.

  • Danaher Corporation

  • F. Hoffmann-La Roche Ltd

  • Qiagen NV

  • Merck KGaA

  • Thermo Fisher Scientific Inc.

*Similar analysis will be provided for each company listed above.

REPORT.png
Pricing Plan
Segmentation
Regional Analysis
Table of Contents
bottom of page